0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Filgotinib Tablets Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-15A18490
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Filgotinib Tablets Market Research Report 2024
BUY CHAPTERS

Global Filgotinib Tablets Market Research Report 2024

Code: QYRE-Auto-15A18490
Report
October 2024
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Filgotinib Tablets Market

Filgotinib tablets are an oral Janus kinase (JAK) inhibitor specifically targeting JAK1, primarily used in the treatment of inflammatory conditions such as rheumatoid arthritis and inflammatory bowel disease.
The global Filgotinib Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Filgotinib Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Filgotinib Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Filgotinib Tablets include Alfasigma, Gilead Sciences, Eisai, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Filgotinib Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Filgotinib Tablets.
The Filgotinib Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Filgotinib Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Filgotinib Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Filgotinib Tablets Market Report

Report Metric Details
Report Name Filgotinib Tablets Market
Segment by Type
  • 100mg per Tablet
  • 200mg per Tablet
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alfasigma, Gilead Sciences, Eisai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Filgotinib Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Filgotinib Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Filgotinib Tablets Market report?

Ans: The main players in the Filgotinib Tablets Market are Alfasigma, Gilead Sciences, Eisai

What are the Application segmentation covered in the Filgotinib Tablets Market report?

Ans: The Applications covered in the Filgotinib Tablets Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Filgotinib Tablets Market report?

Ans: The Types covered in the Filgotinib Tablets Market report are 100mg per Tablet, 200mg per Tablet

Recommended Reports

Kinase Inhibitor Drugs

Inflammatory Disease Drugs

Tablet and API Markets

1 Filgotinib Tablets Market Overview
1.1 Product Definition
1.2 Filgotinib Tablets by Type
1.2.1 Global Filgotinib Tablets Market Value Comparison by Type (2024-2030)
1.2.2 100mg per Tablet
1.2.3 200mg per Tablet
1.3 Filgotinib Tablets by Application
1.3.1 Global Filgotinib Tablets Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Filgotinib Tablets Market Size Estimates and Forecasts
1.4.1 Global Filgotinib Tablets Revenue 2019-2030
1.4.2 Global Filgotinib Tablets Sales 2019-2030
1.4.3 Global Filgotinib Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Filgotinib Tablets Market Competition by Manufacturers
2.1 Global Filgotinib Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Filgotinib Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Filgotinib Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Filgotinib Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Filgotinib Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Filgotinib Tablets, Product Type & Application
2.7 Global Key Manufacturers of Filgotinib Tablets, Date of Enter into This Industry
2.8 Global Filgotinib Tablets Market Competitive Situation and Trends
2.8.1 Global Filgotinib Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Filgotinib Tablets Players Market Share by Revenue
2.8.3 Global Filgotinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Filgotinib Tablets Market Scenario by Region
3.1 Global Filgotinib Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Filgotinib Tablets Sales by Region: 2019-2030
3.2.1 Global Filgotinib Tablets Sales by Region: 2019-2024
3.2.2 Global Filgotinib Tablets Sales by Region: 2025-2030
3.3 Global Filgotinib Tablets Revenue by Region: 2019-2030
3.3.1 Global Filgotinib Tablets Revenue by Region: 2019-2024
3.3.2 Global Filgotinib Tablets Revenue by Region: 2025-2030
3.4 North America Filgotinib Tablets Market Facts & Figures by Country
3.4.1 North America Filgotinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Filgotinib Tablets Sales by Country (2019-2030)
3.4.3 North America Filgotinib Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Filgotinib Tablets Market Facts & Figures by Country
3.5.1 Europe Filgotinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Filgotinib Tablets Sales by Country (2019-2030)
3.5.3 Europe Filgotinib Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Filgotinib Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Filgotinib Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Filgotinib Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Filgotinib Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Filgotinib Tablets Market Facts & Figures by Country
3.7.1 Latin America Filgotinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Filgotinib Tablets Sales by Country (2019-2030)
3.7.3 Latin America Filgotinib Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Filgotinib Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Filgotinib Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Filgotinib Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Filgotinib Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Filgotinib Tablets Sales by Type (2019-2030)
4.1.1 Global Filgotinib Tablets Sales by Type (2019-2024)
4.1.2 Global Filgotinib Tablets Sales by Type (2025-2030)
4.1.3 Global Filgotinib Tablets Sales Market Share by Type (2019-2030)
4.2 Global Filgotinib Tablets Revenue by Type (2019-2030)
4.2.1 Global Filgotinib Tablets Revenue by Type (2019-2024)
4.2.2 Global Filgotinib Tablets Revenue by Type (2025-2030)
4.2.3 Global Filgotinib Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Filgotinib Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Filgotinib Tablets Sales by Application (2019-2030)
5.1.1 Global Filgotinib Tablets Sales by Application (2019-2024)
5.1.2 Global Filgotinib Tablets Sales by Application (2025-2030)
5.1.3 Global Filgotinib Tablets Sales Market Share by Application (2019-2030)
5.2 Global Filgotinib Tablets Revenue by Application (2019-2030)
5.2.1 Global Filgotinib Tablets Revenue by Application (2019-2024)
5.2.2 Global Filgotinib Tablets Revenue by Application (2025-2030)
5.2.3 Global Filgotinib Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Filgotinib Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Alfasigma
6.1.1 Alfasigma Company Information
6.1.2 Alfasigma Description and Business Overview
6.1.3 Alfasigma Filgotinib Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Alfasigma Filgotinib Tablets Product Portfolio
6.1.5 Alfasigma Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Company Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Filgotinib Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Gilead Sciences Filgotinib Tablets Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Company Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Filgotinib Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eisai Filgotinib Tablets Product Portfolio
6.3.5 Eisai Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Filgotinib Tablets Industry Chain Analysis
7.2 Filgotinib Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Filgotinib Tablets Production Mode & Process
7.4 Filgotinib Tablets Sales and Marketing
7.4.1 Filgotinib Tablets Sales Channels
7.4.2 Filgotinib Tablets Distributors
7.5 Filgotinib Tablets Customers
8 Filgotinib Tablets Market Dynamics
8.1 Filgotinib Tablets Industry Trends
8.2 Filgotinib Tablets Market Drivers
8.3 Filgotinib Tablets Market Challenges
8.4 Filgotinib Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Filgotinib Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Filgotinib Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Filgotinib Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Filgotinib Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Filgotinib Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Filgotinib Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Filgotinib Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Filgotinib Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Filgotinib Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Filgotinib Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Filgotinib Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Filgotinib Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Filgotinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Filgotinib Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Filgotinib Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Filgotinib Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Filgotinib Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Filgotinib Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Filgotinib Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Filgotinib Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Filgotinib Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Filgotinib Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Filgotinib Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Filgotinib Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Filgotinib Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Filgotinib Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Filgotinib Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Filgotinib Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Filgotinib Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Filgotinib Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Filgotinib Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Filgotinib Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Filgotinib Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Filgotinib Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Filgotinib Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Filgotinib Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Filgotinib Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Filgotinib Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Filgotinib Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Filgotinib Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Filgotinib Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Filgotinib Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Filgotinib Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Filgotinib Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Filgotinib Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Filgotinib Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Filgotinib Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Filgotinib Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Filgotinib Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Filgotinib Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Filgotinib Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Filgotinib Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Filgotinib Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Filgotinib Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Filgotinib Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Filgotinib Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Filgotinib Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Filgotinib Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Filgotinib Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Filgotinib Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Filgotinib Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Filgotinib Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Filgotinib Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Filgotinib Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Filgotinib Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Filgotinib Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Filgotinib Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Filgotinib Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. Alfasigma Company Information
 Table 71. Alfasigma Description and Business Overview
 Table 72. Alfasigma Filgotinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Alfasigma Filgotinib Tablets Product
 Table 74. Alfasigma Recent Developments/Updates
 Table 75. Gilead Sciences Company Information
 Table 76. Gilead Sciences Description and Business Overview
 Table 77. Gilead Sciences Filgotinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Gilead Sciences Filgotinib Tablets Product
 Table 79. Gilead Sciences Recent Developments/Updates
 Table 80. Eisai Company Information
 Table 81. Eisai Description and Business Overview
 Table 82. Eisai Filgotinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Eisai Filgotinib Tablets Product
 Table 84. Eisai Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Filgotinib Tablets Distributors List
 Table 88. Filgotinib Tablets Customers List
 Table 89. Filgotinib Tablets Market Trends
 Table 90. Filgotinib Tablets Market Drivers
 Table 91. Filgotinib Tablets Market Challenges
 Table 92. Filgotinib Tablets Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Filgotinib Tablets
 Figure 2. Global Filgotinib Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Filgotinib Tablets Market Share by Type: 2023 & 2030
 Figure 4. 100mg per Tablet Product Picture
 Figure 5. 200mg per Tablet Product Picture
 Figure 6. Global Filgotinib Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Filgotinib Tablets Market Share by Application: 2023 & 2030
 Figure 8. Hospital Pharmacy
 Figure 9. Retail Pharmacy
 Figure 10. Online Pharmacy
 Figure 11. Global Filgotinib Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Filgotinib Tablets Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Filgotinib Tablets Sales (2019-2030) & (K Units)
 Figure 14. Global Filgotinib Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 15. Filgotinib Tablets Report Years Considered
 Figure 16. Filgotinib Tablets Sales Share by Manufacturers in 2023
 Figure 17. Global Filgotinib Tablets Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Filgotinib Tablets Players: Market Share by Revenue in Filgotinib Tablets in 2023
 Figure 19. Filgotinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Filgotinib Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Filgotinib Tablets Sales Market Share by Country (2019-2030)
 Figure 22. North America Filgotinib Tablets Revenue Market Share by Country (2019-2030)
 Figure 23. United States Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Filgotinib Tablets Sales Market Share by Country (2019-2030)
 Figure 26. Europe Filgotinib Tablets Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Filgotinib Tablets Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Filgotinib Tablets Revenue Market Share by Region (2019-2030)
 Figure 34. China Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Filgotinib Tablets Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Filgotinib Tablets Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Filgotinib Tablets Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Filgotinib Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Filgotinib Tablets by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Filgotinib Tablets by Type (2019-2030)
 Figure 53. Global Filgotinib Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Filgotinib Tablets by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Filgotinib Tablets by Application (2019-2030)
 Figure 56. Global Filgotinib Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 57. Filgotinib Tablets Value Chain
 Figure 58. Filgotinib Tablets Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools